Opportunity Information: Apply for RFA OD 23 021
The grant opportunity "Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)" (RFA-OD-23-021) is a discretionary federal funding program run by the National Institutes of Health (NIH) using funds provided by the FDA Center for Tobacco Products (CTP). It supports tobacco regulatory science under the authority of the Family Smoking Prevention and Tobacco Control Act (FSPTCA, P.L. 111-31). The central goal is to fund health communication research that tests and clarifies how different kinds of public health messages about the "continuum of risk" across tobacco products influence people’s understanding, perceptions, and likely behaviors. In plain terms, it is aimed at figuring out what happens when the public is told that different tobacco products may carry different levels of harm, and how that information lands with different groups.
The research focus is on messaging effects across "various segments of the population," which typically means examining differences by age, tobacco use status (for example, non-users, current cigarette smokers, people who use multiple products), and other characteristics that can shape how risk information is processed. Because the NOFO is built around health communication, it emphasizes understanding outcomes like comprehension of risk messages, perceived harm, trust and credibility, intentions to use or stop using products, and potential unintended consequences (such as misunderstandings that could increase initiation or reduce quitting). The intent is to generate evidence that is directly relevant to FDA’s regulatory responsibilities, meaning studies should be designed to produce findings that can inform how tobacco-related risk information might be communicated to the public in ways that protect public health.
The funding mechanism is a U01 cooperative agreement, which generally means the project is a research grant but with substantial scientific or programmatic involvement from the funding agency compared to a standard investigator-initiated award. The title also specifies "Clinical Trial Required," indicating the program expects applications to include a clinical trial as defined by NIH rules. In practice, for communication research this often involves experimental or intervention-style studies where participants are assigned to different message conditions and outcomes are measured, rather than purely observational work.
Eligibility is broad across government, academic, nonprofit, and private-sector organizations. Eligible applicants listed include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education for those categories as specified in the listing); for-profit organizations (other than small businesses); and small businesses. The NOFO also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, Indian/Native American Tribal Governments other than federally recognized ones, and U.S. territories or possessions.
At the same time, it places clear limits on foreign involvement. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. However, "foreign components" as defined in the NIH Grants Policy Statement are allowed, which typically means specific parts of an otherwise eligible U.S.-led project may be carried out outside the United States if justified and approved under NIH policy.
Administratively, the program is categorized under a health funding activity (CFDA/Assistance Listing 93.077). The opportunity was created on 2023-08-01 and had an original closing date of 2023-12-06. The listed award ceiling is $2,500,000, signaling that the agency anticipated potentially large, multi-year, or resource-intensive projects consistent with a cooperative agreement that includes a clinical trial component. Overall, this NOFO is aimed at producing rigorous, policy-relevant evidence about how to communicate nuanced tobacco risk information without causing confusion or unintended harm, and to understand how those messages play out across different audiences in the real world.Apply for RFA OD 23 021
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.077.
- This funding opportunity was created on 2023-08-01.
- Applicants must submit their applications by 2023-12-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $2,500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
Previous opportunity: Cooperative Agreement for CESU Partner with Californian Cooperative Ecosystem Studies Unit
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OD 23 021
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OD 23 021) also looked into and applied for these:
| Funding Opportunity |
|---|
| Validating digital health technologies for monitoring biomarkers in ADRD clinical trials (R61/R33 - Clinical Trials Optional) Apply for RFA NS 24 026 Funding Number: RFA NS 24 026 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 23 252 Funding Number: PAR 23 252 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PAR 23 251 Funding Number: PAR 23 251 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required) Apply for RFA AG 24 045 Funding Number: RFA AG 24 045 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) Apply for PAR 23 250 Funding Number: PAR 23 250 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) Apply for PAR 23 249 Funding Number: PAR 23 249 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed) Apply for RFA NS 24 006 Funding Number: RFA NS 24 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed) Apply for RFA AG 24 028 Funding Number: RFA AG 24 028 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed) Apply for RFA AG 24 029 Funding Number: RFA AG 24 029 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed) Apply for RFA NS 24 007 Funding Number: RFA NS 24 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) Apply for RFA AG 24 041 Funding Number: RFA AG 24 041 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) Apply for RFA AG 24 042 Funding Number: RFA AG 24 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) Apply for PAR 24 029 Funding Number: PAR 24 029 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity Apply for 72065623APS00001 Funding Number: 72065623APS00001 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $92,000,000 |
| Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) Apply for PAR 23 258 Funding Number: PAR 23 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 24 043 Funding Number: RFA AG 24 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed) Apply for RFA NS 24 027 Funding Number: RFA NS 24 027 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) Apply for RFA NS 23 030 Funding Number: RFA NS 23 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) Apply for PA 23 290 Funding Number: PA 23 290 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for PA 23 291 Funding Number: PA 23 291 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 23 021", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
